15 completed, 5 unknown, 2 recruiting, 1 not yet recruiting. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Completed 15, Unknown 5, Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study) Varenicline, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham - Nicotine Dependence, Transcranial Magnetic Stimulation | Phase 4 | Recruiting | Massachusetts General Hospital | 30 | 2026-07-02 | 2026-09-15 |
| Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking Daridorexant 50 mg, Placebo - Smoking, Nicotine | Phase 4 | Not yet recruiting | Legacy Health System | 44 | 2026-02-10 | 2026-01-09 |
| Addiction Potential of Very Low Nicotine Filtered Little Cigars Reduced Nicotine Content Cigars, Normal nicotine content cigar, Usual brand cigar - Smoking (Tobacco) Addiction | Phase 4 | Recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2025-02-13 | 2026-10-29 |
| Clinical Study of Ligustrazine in Treating Alcohol Addiction Ligustrazine by intravenously administration, Ligustrazine by mouth, Placebo by intravenously administration - Alcohol Abuse, Arteriosclerosis | Phase 4 | Unknown | Shenzhen Kangning Hospital | 400 | 2023-07-28 | 2023-10-16 |
| Impact of Tramadol Addiction On Dental Anesthesia Success articaine@ (4% 1:100000 epinephrine) dental anesthesia - Dental Pain and Sensation Disorder, Anesthesia, Local | Phase 4 | Unknown | University of Algiers | 300 | 2023-06-10 | 2023-06-18 |
| Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder Cariprazine - Attention Deficit Hyperactivity Disorder | Phase 4 | Unknown | Dr. Martin A. Katzman | 15 | 2021-12-01 | 2021-12-14 |
| Toward Zero Prescribed Opioids for Outpatient General Surgery Oxycodone, Zero Opioid Protocol - Opioid Misuse and Addiction, Pain | Phase 4 | Completed | Thomas Jefferson University | 129 | 2019-11-01 | 2023-06-05 |
| Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial. Alcohol N-acetylcysteine, Alcohol Placebo, Cocaine N-acetylcysteine - Cocaine Addiction, Alcohol Addiction | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 100 | 2017-01-01 | 2017-01-24 |
| Comparison of Tramacet Versus Percocet in Post Surgical Patients Tramacet, Percocet - Post Operative Pain | Phase 4 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 160 | 2015-04-01 | 2018-11-06 |
| Desvenlafaxine in Opioid-Dependent Patients Desvenlafaxine - Depression, Opioid Dependence | Phase 4 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 18 | 2014-07-01 | 2020-10-23 |
| Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor Tolcapone, Placebo, Bromocriptine - Addiction | Phase 4 | Withdrawn | University of California, Berkeley | 2013-07-01 | 2021-11-16 | |
| Attention Training for Opioid-maintained Cocaine Users Attentional retraining, Control condition - Addiction, Cocaine | Phase 4 | Completed | Yale University | 8 | 2013-06-01 | 2020-04-02 |
| Biomarkers of Injectable Extended Release Naltrexone Treatment Naltrexone - Heroin Dependence, Opioid Dependence | Phase 4 | Completed | University of Pennsylvania | 32 | 2011-10-01 | 2023-01-12 |
| Impaired Decision Making in Pedophilic Offenders neuropsychological questionnaires - Pedophilia | Phase 4 | Unknown | University Hospital, Montpellier | 128 | 2011-08-01 | 2014-12-31 |
| Treatment of Alcohol Dependence and Comorbid Bipolar Disorder Lamotrigine, Placebo - Alcohol Dependence, Bipolar Disorder | Phase 4 | Completed | Medical University of South Carolina | 43 | 2010-02-01 | 2019-01-09 |
| Naltrexone for Impulse Control Disorders in Parkinson's Disease Naltrexone, Placebo - Impulse Control Disorder, Parkinson Disease | Phase 4 | Completed | University of Pennsylvania | 50 | 2009-11-01 | 2015-08-06 |
| FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders Aripiprazole - Autism Spectrum Disorder | Phase 4 | Completed | University of North Carolina, Chapel Hill | 13 | 2009-08-01 | 2014-03-11 |
| Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD) atomoxetine (or placebo) - Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | University of Arizona | 5 | 2009-03-01 | 2012-07-09 |
| Effects of Modafinil in Methamphetamine Dependence Modafinil, Placebo - Methamphetamine Dependence | Phase 4 | Completed | Medical University of South Carolina | 40 | 2009-02-01 | 2019-06-13 |
| ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults VIVITROL 380 mg, Placebo - Alcohol Dependence | Phase 4 | Completed | Alkermes, Inc. | 31 | 2007-07-01 | 2017-07-11 |
Showing 20 of 24. Sign in to see all of them.
Behavior, Addictive (16) · Opioid-Related Disorders (5) · Alcoholism (4) · Substance-Related Disorders (4) · Cocaine-Related Disorders (3) · Smoking (3) · Attention Deficit Disorder with Hyperactivity (2) · Compulsive Behavior (2) · Depression (2) · Aggression (1) · Anxiety Disorders (1) · Arteriosclerosis (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1)
Behavior (24) · Compulsive Behavior (18) · Mental Disorders (18) · Chemically-Induced Disorders (12) · Substance-Related Disorders (8) · Narcotic-Related Disorders (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Alcohol-Related Disorders (4) · Behavioral Symptoms (4) · Neurodevelopmental Disorders (3) · Attention Deficit and Disruptive Behavior Disorders (2)
Naltrexone (3) · vivitrol (3) · Oxycodone (2) · Acetaminophen (1) · Anesthesia, Dental (1) · Aripiprazole (1) · Atomoxetine Hydrochloride (1) · Bromocriptine (1) · Carticaine (1) · Cycloserine (1) · Desvenlafaxine Succinate (1) · Duloxetine Hydrochloride (1) · Epinephrine (1) · Escitalopram (1) · Ethanol (1)
Massachusetts General Hospital (2) · Medical University of South Carolina (2) · University of Pennsylvania (2) · Alkermes, Inc. (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Dr. Martin A. Katzman (1) · Hospital de Clinicas de Porto Alegre (1) · Icahn School of Medicine at Mount Sinai (1) · Legacy Health System (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Nathan Kline Institute for Psychiatric Research (1) · Ohio State University Comprehensive Cancer Center (1) · Seattle Institute for Biomedical and Clinical Research (1) · Shenzhen Kangning Hospital (1) · Thomas Jefferson University (1)
United States (15) · Canada (3) · Brazil (1) · China (1) · France (1)
Bryan K Tolliver, MD, PhD (2) · Andre Tapp, M.D. (1) · Andrew Kayser, MD,PhD (1) · Cheryl O Alderman, BS (1) · Collin Clarke, MD (1) · Daniel Langleben, MD (1) · Daniel Weintraub, MD (1) · Darin D Dougherty, MD (1) · Dharini M Bhammar, PhD, MBBS (1) · Didier Jutras-Aswad, M.D., M.Sc. (1) · Eric Hollander, MD (1) · Flavio Pechansky, PhD (1) · Francesco Palazzo, MD (1) · Gabriel Dichter, PhD (1)
PMID 17917554, PMID 18312057, PMID 23571420, PMID 25037206, PMID 25637377, PMID 29738425, PMID 32379516
K23AA017666 (1), K23MH081285 (1)